Thus, the low surface CD25 expression observed in canine CD4+ PTCL in our study could indicate a tumorigenesis event somewhere around the time of DN or DP thymocyte development. This evidence concerns the gene IL2RA and mature T-cell and NK-cell non-Hodgkin lymphoma.